Diagnostik und Therapie von Tuberkulose unter Immuntherapien für Multiple Sklerose: Aktueller Stand und Empfehlungen in Deutschland

Stefan Bittner; Sinah Engel; Christoph Lange; Martin S. Weber; Aiden Haghikia; Felix Luessi; Thomas Korn; Luisa Klotz; Antonios Bayas; Friedemann Paul; Christoph Heesen; Martin Stangel; Brigitte Wildemann; Florian Then Bergh; Björn Tackenberg; Corinna Trebst; Clemens Warnke; Ralf Linker; Martin Kerschensteiner; Uwe Zettl; Hayrettin Tumani; Wolfgang Brück; Sven G. Meuth; Tanja Kümpfel; Bernhard Hemmer; Heinz Wiendl; Ralf Gold; Frauke Zipp

doi:10.1007/s00115-019-0760-0

Diagnostik und Therapie von Tuberkulose unter Immuntherapien für Multiple Sklerose: Aktueller Stand und Empfehlungen in Deutschland

Stefan Bittner, Sinah Engel, Christoph Lange, Martin S. Weber, Aiden Haghikia, Felix Luessi, Thomas Korn, Luisa Klotz, Antonios Bayas, Friedemann Paul, Christoph Heesen, Martin Stangel, Brigitte Wildemann, Florian Then Bergh, Björn Tackenberg, Corinna Trebst, Clemens Warnke, Ralf Linker, Martin Kerschensteiner, Uwe ZettlHayrettin Tumani, Wolfgang Brück, Sven G. Meuth, Tanja Kümpfel, Bernhard Hemmer, Heinz Wiendl, Ralf Gold, Frauke Zipp

Publikation: Beitrag in Fachzeitschrift › Übersichtsartikel › Begutachtung

4 Zitate (Scopus)

Abstract

After years of low incidence, a large increase of new tuberculosis (TB) cases has been reported in Germany since 2015. New immunotherapies for the treatment of multiple sclerosis (MS) are associated with a reduced immune competence and a potential increased risk for infections. Most neurologists lack specific experiences with TB infections. This article summarizes specific recommendations for the diagnostics and treatment of TB under MS immunotherapies with a focus on the situation in Germany. Due to low case numbers and little experience with the risk of TB under the new immunotherapies, the clinical competence network for MS (KKNMS) consensus recommendations have a low grade of evidence.

Titel in Übersetzung	Diagnostics and treatment of tuberculosis under immunotherapy for multiple sclerosis: Current status and recommendations in Germany
Originalsprache	Deutsch
Seiten (von - bis)	1245-1253
Seitenumfang	9
Fachzeitschrift	Nervenarzt
Jahrgang	90
Ausgabenummer	12
DOIs	https://doi.org/10.1007/s00115-019-0760-0
Publikationsstatus	Veröffentlicht - 1 Dez. 2019
Extern publiziert	Ja

Schlagwörter

Immune monitoring
Multiple sclerosis
Prevention
Treatment
Tuberculosis

Zugriff auf Dokument

10.1007/s00115-019-0760-0

Andere Dateien und Links

Verknüpfung zur Publikation in Scopus

Dieses zitieren

Bittner, S., Engel, S., Lange, C., Weber, M. S., Haghikia, A., Luessi, F., Korn, T., Klotz, L., Bayas, A., Paul, F., Heesen, C., Stangel, M., Wildemann, B., Bergh, F. T., Tackenberg, B., Trebst, C., Warnke, C., Linker, R., Kerschensteiner, M., ... Zipp, F. (2019). Diagnostik und Therapie von Tuberkulose unter Immuntherapien für Multiple Sklerose: Aktueller Stand und Empfehlungen in Deutschland. Nervenarzt, 90(12), 1245-1253. https://doi.org/10.1007/s00115-019-0760-0

@article{e7d49762f37642628555c1b896b695d0,

title = "Diagnostik und Therapie von Tuberkulose unter Immuntherapien f{\"u}r Multiple Sklerose: Aktueller Stand und Empfehlungen in Deutschland",

abstract = "After years of low incidence, a large increase of new tuberculosis (TB) cases has been reported in Germany since 2015. New immunotherapies for the treatment of multiple sclerosis (MS) are associated with a reduced immune competence and a potential increased risk for infections. Most neurologists lack specific experiences with TB infections. This article summarizes specific recommendations for the diagnostics and treatment of TB under MS immunotherapies with a focus on the situation in Germany. Due to low case numbers and little experience with the risk of TB under the new immunotherapies, the clinical competence network for MS (KKNMS) consensus recommendations have a low grade of evidence.",

keywords = "Immune monitoring, Multiple sclerosis, Prevention, Treatment, Tuberculosis",

author = "Stefan Bittner and Sinah Engel and Christoph Lange and Weber, {Martin S.} and Aiden Haghikia and Felix Luessi and Thomas Korn and Luisa Klotz and Antonios Bayas and Friedemann Paul and Christoph Heesen and Martin Stangel and Brigitte Wildemann and Bergh, {Florian Then} and Bj{\"o}rn Tackenberg and Corinna Trebst and Clemens Warnke and Ralf Linker and Martin Kerschensteiner and Uwe Zettl and Hayrettin Tumani and Wolfgang Br{\"u}ck and Meuth, {Sven G.} and Tanja K{\"u}mpfel and Bernhard Hemmer and Heinz Wiendl and Ralf Gold and Frauke Zipp",

note = "Publisher Copyright: {\textcopyright} 2019, Springer Medizin Verlag GmbH, ein Teil von Springer Nature.",

year = "2019",

month = dec,

day = "1",

doi = "10.1007/s00115-019-0760-0",

language = "Deutsch",

volume = "90",

pages = "1245--1253",

journal = "Nervenarzt",

issn = "0028-2804",

publisher = "Springer Verlag",

number = "12",

}

Bittner, S, Engel, S, Lange, C, Weber, MS, Haghikia, A, Luessi, F, Korn, T, Klotz, L, Bayas, A, Paul, F, Heesen, C, Stangel, M, Wildemann, B, Bergh, FT, Tackenberg, B, Trebst, C, Warnke, C, Linker, R, Kerschensteiner, M, Zettl, U, Tumani, H, Brück, W, Meuth, SG, Kümpfel, T, Hemmer, B, Wiendl, H, Gold, R & Zipp, F 2019, 'Diagnostik und Therapie von Tuberkulose unter Immuntherapien für Multiple Sklerose: Aktueller Stand und Empfehlungen in Deutschland', Nervenarzt, Jg. 90, Nr. 12, S. 1245-1253. https://doi.org/10.1007/s00115-019-0760-0

TY - JOUR

T1 - Diagnostik und Therapie von Tuberkulose unter Immuntherapien für Multiple Sklerose

T2 - Aktueller Stand und Empfehlungen in Deutschland

AU - Bittner, Stefan

AU - Engel, Sinah

AU - Lange, Christoph

AU - Weber, Martin S.

AU - Haghikia, Aiden

AU - Luessi, Felix

AU - Korn, Thomas

AU - Klotz, Luisa

AU - Bayas, Antonios

AU - Paul, Friedemann

AU - Heesen, Christoph

AU - Stangel, Martin

AU - Wildemann, Brigitte

AU - Bergh, Florian Then

AU - Tackenberg, Björn

AU - Trebst, Corinna

AU - Warnke, Clemens

AU - Linker, Ralf

AU - Kerschensteiner, Martin

AU - Zettl, Uwe

AU - Tumani, Hayrettin

AU - Brück, Wolfgang

AU - Meuth, Sven G.

AU - Kümpfel, Tanja

AU - Hemmer, Bernhard

AU - Wiendl, Heinz

AU - Gold, Ralf

AU - Zipp, Frauke

PY - 2019/12/1

Y1 - 2019/12/1

N2 - After years of low incidence, a large increase of new tuberculosis (TB) cases has been reported in Germany since 2015. New immunotherapies for the treatment of multiple sclerosis (MS) are associated with a reduced immune competence and a potential increased risk for infections. Most neurologists lack specific experiences with TB infections. This article summarizes specific recommendations for the diagnostics and treatment of TB under MS immunotherapies with a focus on the situation in Germany. Due to low case numbers and little experience with the risk of TB under the new immunotherapies, the clinical competence network for MS (KKNMS) consensus recommendations have a low grade of evidence.

AB - After years of low incidence, a large increase of new tuberculosis (TB) cases has been reported in Germany since 2015. New immunotherapies for the treatment of multiple sclerosis (MS) are associated with a reduced immune competence and a potential increased risk for infections. Most neurologists lack specific experiences with TB infections. This article summarizes specific recommendations for the diagnostics and treatment of TB under MS immunotherapies with a focus on the situation in Germany. Due to low case numbers and little experience with the risk of TB under the new immunotherapies, the clinical competence network for MS (KKNMS) consensus recommendations have a low grade of evidence.

KW - Immune monitoring

KW - Multiple sclerosis

KW - Prevention

KW - Treatment

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=85069651235&partnerID=8YFLogxK

U2 - 10.1007/s00115-019-0760-0

DO - 10.1007/s00115-019-0760-0

M3 - Übersichtsartikel

C2 - 31297574

AN - SCOPUS:85069651235

SN - 0028-2804

VL - 90

SP - 1245

EP - 1253

JO - Nervenarzt

JF - Nervenarzt

IS - 12

ER -

Diagnostik und Therapie von Tuberkulose unter Immuntherapien für Multiple Sklerose: Aktueller Stand und Empfehlungen in Deutschland

Abstract

Schlagwörter

Zugriff auf Dokument

Andere Dateien und Links

Fingerprint

Dieses zitieren